| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/25/2011 | CN101273046B Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists |
| 05/25/2011 | CN101237870B Concomitant pharmaceutical agents and use thereof |
| 05/25/2011 | CN101213184B Heteroaryl-substituted amides comprising an unsaturated or cyclic linker group, and their use as pharmaceuticals |
| 05/25/2011 | CN101185759B Anti-angiogene compositions and methods of use |
| 05/25/2011 | CN101137387B Pharmaceutical composition and method for neoangiogenesis/revascularization useful in treating ischemic heart diseases |
| 05/25/2011 | CN101062037B Process for their preparation of thioxanthine derivatives, their use |
| 05/25/2011 | CN101056628B Ester derivatives and medicinal use thereof |
| 05/24/2011 | US7947735 Compounds for the treatment of metabolic disorders |
| 05/24/2011 | US7947720 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 05/24/2011 | US7947693 5,7-disubstituted thiazolo[4,5-D]pyrimidines as chemokine inhibitors |
| 05/24/2011 | US7947684 anticoagulants; immunomoderators; antiinflammatory agents |
| 05/24/2011 | US7947498 Embryonic stem cells and neural progenitor cells derived therefrom |
| 05/24/2011 | US7947458 Placental human neurokinin B precursor |
| 05/24/2011 | US7947299 Compositions and techniques for localized therapy |
| 05/24/2011 | US7947266 Perivascular mesenchymal precursor cells |
| 05/24/2011 | CA2633170C Butylphthalide intravenous emulsion and application thereof |
| 05/24/2011 | CA2493026C Vegfr-2 and vegfr-3 inhibitory anthranilamide pyridines |
| 05/24/2011 | CA2490239C Substituted 2,4-dihydro-pyrrolo (3, 4-b) -quinolin-9-one derivatives useful as phosphodiesterase inhibitors |
| 05/24/2011 | CA2477601C 5-phenylthiazole derivatives and use as pi3 kinase inhibitors |
| 05/24/2011 | CA2467552C Nicotin-or isonicotin benzothiazole derivatives |
| 05/24/2011 | CA2453901C Substituted 4-aminocyclohexanols |
| 05/24/2011 | CA2443952C Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors |
| 05/24/2011 | CA2393710C Caspase inhibitors and uses thereof |
| 05/24/2011 | CA2384378C Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 05/24/2011 | CA2358459C Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions |
| 05/24/2011 | CA2345201C Mature protein having antagonistic activity against bone morphogenetic protein |
| 05/24/2011 | CA2341507C Porphyrin derivatives, their use in photodynamic therapy and medical devices containing them |
| 05/24/2011 | CA2266640C Methods for treating an ischemic disorder and improving stroke outcome |
| 05/24/2011 | CA2211687C Vascular endothelial growth factor-b |
| 05/19/2011 | WO2011059784A1 Tricyclic heterocyclic compounds |
| 05/19/2011 | WO2011059085A1 Prophylactic or therapeutic agent for dyslipidemia-related arteriosclerosis |
| 05/19/2011 | WO2011059080A1 Isotope-substituted diamine derivative |
| 05/19/2011 | WO2011059021A1 8-azabicyclo[3.2.1]octane-8-carboxamide derivative |
| 05/19/2011 | WO2011058975A1 Agent for ameliorating postprandial hyperglycemia, and pyrrolidine iminosugar or salt thereof |
| 05/19/2011 | WO2011058943A1 Pharmaceutical composition formed from combining compound having mch r1 antagonist activity and compound having npy y5 antagonist activity |
| 05/19/2011 | WO2011058813A1 Cell sheet for myocardial regeneration, manufacturing method, and method of usage therefor |
| 05/19/2011 | WO2011058766A1 Aryl carboxamide derivatives as ttx-s blockers |
| 05/19/2011 | WO2011058331A1 Pemirolast for the treatment of systemic low grade inflammation |
| 05/19/2011 | WO2011058182A1 Osteopontin-conditioned medium for the treatment of vascular diseases |
| 05/19/2011 | WO2011058113A1 Fused bicyclic pyridine and pyrazine derivatives as kinase inhibitors |
| 05/19/2011 | WO2011058110A1 Quinoline and quinoxaline derivatives as kinase inhibitors |
| 05/19/2011 | WO2011058109A1 Fused bicyclic pyrrole and imidazole derivatives as kinase inhibitors |
| 05/19/2011 | WO2011058108A1 Quinoline and quinoxaline derivatives as kinase inhibitors |
| 05/19/2011 | WO2011057471A1 Methods and compositions for treating disease or condition related to orexin receptor 1, orexin receptor 2, somatostatin receptor 2 or dopamine d2l receptor |
| 05/19/2011 | WO2011057397A1 Methods for treating or preventing heart damage with integrin-linked kinase (ilk) compositions |
| 05/19/2011 | WO2011057382A1 Spirocyclic piperidine derivatives useful as renin inhibitors |
| 05/19/2011 | WO2011057340A1 Process for plant bioactive enrichment |
| 05/19/2011 | WO2011018582A3 Floating microgranules |
| 05/19/2011 | WO2011008028A3 Functional drinking water for improving blood circulation, and method for preparing same |
| 05/19/2011 | WO2011008001A3 Antihypertensive composition containing a ginsenoside-enriched fraction |
| 05/19/2011 | WO2011006072A3 Cardioprotective role of hepatic cells and hepatocyte secretory factors in myocardial ischemia |
| 05/19/2011 | WO2010151080A3 Pharmaceutical composition containing carboxylosartan and a production method therefor |
| 05/19/2011 | WO2010151004A3 Injectable composition containing hydroxychloroquine for local administration for treating hemorrhoids |
| 05/19/2011 | WO2010140855A3 Pharmaceutical composition or functional food composition for the treatment, prevention or alleviation of cardiac hypertrophy comprising raspberry extract |
| 05/19/2011 | WO2010131910A9 Composition for improving blood circulation containing fermented tea, and pharmaceutical and health-food compositions comprising the same |
| 05/19/2011 | WO2010111634A3 Renin inhibitors |
| 05/19/2011 | US20110118825 Anti-angiogenic compositions and methods of use |
| 05/19/2011 | US20110118470 Nitrogen-containing aromatic derivatives |
| 05/19/2011 | US20110118354 Cyclohexenyl modulators of chemokine receptor activity |
| 05/19/2011 | US20110118350 Composition for preventing cardiovascular event in high-risk patient |
| 05/19/2011 | US20110118344 Novel compound having inhibitory effect on lipase |
| 05/19/2011 | US20110118333 Use on Minicircle vectors for cardiac gene therapy |
| 05/19/2011 | US20110118329 Uses of ion channel modulating compounds |
| 05/19/2011 | US20110118328 Novel crystalline forms |
| 05/19/2011 | US20110118315 5-lipoxygenase-activating protein (flap) inhibitors |
| 05/19/2011 | US20110118302 Preparation and use of biphenyl-4-yl-carbonylamino acid derivatives for the treatment of obesity |
| 05/19/2011 | US20110118301 Amino-Aza-Adamantane Derivatives and Methods of Use |
| 05/19/2011 | US20110118292 Method of treating atherosclerosis, dyslipidemias and related conditions |
| 05/19/2011 | US20110118288 Pharmaceutical composition for treating hypertension and metabolic syndrome and use thereof |
| 05/19/2011 | US20110118287 Bicycloheteroaryl Compounds As P2X7 Modulators and Uses Thereof |
| 05/19/2011 | US20110118282 Soluble Guanylate Cyclase Activators |
| 05/19/2011 | US20110118276 Methods of treating atherosclerosis |
| 05/19/2011 | US20110118273 Pyrrolo-pyridine, pyrrolo-pyrimidine and related heterocyclic compounds |
| 05/19/2011 | US20110118271 Kinase Inhibitors Useful For The Treatment Of Proliferative Diseases |
| 05/19/2011 | US20110118269 Fused pyrazine compounds as their salts, useful for the treatment of degenerative and inflammatory diseases |
| 05/19/2011 | US20110118268 Novel 1,4-diaza-bicyclo[3.2.1]octane derivatives useful as nicotinic acetylcholine receptor modulators |
| 05/19/2011 | US20110118262 Pyrrolidinyl and Piperidinyl Compounds Useful as NHE-1 Inhibitiors |
| 05/19/2011 | US20110118261 Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists |
| 05/19/2011 | US20110118257 Novel kinase modulators |
| 05/19/2011 | US20110118248 Heteroaryl sulfonamides and CCR2/CCR9 |
| 05/19/2011 | US20110118247 2-Methyl-5-Imino-Benzo[D][1,3]Oxazin[5-B]Pyrazole Compound, Preparation and Use Thereof |
| 05/19/2011 | US20110118246 Novel Compounds |
| 05/19/2011 | US20110118244 Factor xa inhibitors |
| 05/19/2011 | US20110118241 6-Pyridin-3-YL-3,4-Dihydro-1H-Quinolin-2-One Derivatives and Related Compounds as Inhibitors of the Human Aldosterone Synthase CYP11B2 |
| 05/19/2011 | US20110118231 Modulators of 5-ht receptors and methods of use thereof |
| 05/19/2011 | US20110118228 Enzymatic production or chemical synthesis and uses for 5,7-dienes and UVB conversion products thereof |
| 05/19/2011 | US20110118221 1,4-diaryl-pyrimidopyridazine-2,5-diones and their use |
| 05/19/2011 | US20110118218 Treating hypertension with 25-hydroxyvitamin d3 |
| 05/19/2011 | US20110118213 Compounds and methods for delivery of prostacyclin analogs |
| 05/19/2011 | US20110118211 Novel glucokinase activators and methods of using same |
| 05/19/2011 | US20110118201 Glutathione production enhancer, prophylactic/therapeutic agent for diseases caused by glutathione deficiency, and food, beverage and feed |
| 05/19/2011 | US20110118197 Prevention of hepatic ischemic reperfusion injury by administration of sulfatides |
| 05/19/2011 | US20110118186 Synthetic peptide amides and dimeric forms thereof |
| 05/19/2011 | US20110118173 Method of delipidation of hdl using serum opacity factor to prevent, inhibit, and/or reverse atherosclerosis |
| 05/19/2011 | US20110117646 Antisense modulation of c-reactive protein expression |
| 05/19/2011 | US20110117224 Composition Comprising Bamboo Extract and the Compounds Isolated Therefrom Showing Treating and Preventing Activity for Inflammatory and Blood Circulation Disease |
| 05/19/2011 | US20110117195 Method for improving myocardial infarction by intramyocardial or transendocardial injection of peptide nanofibers |
| 05/19/2011 | US20110117191 Mixture of substances on the basis of a mixture of essential oils and use |
| 05/19/2011 | US20110117185 Methods for treating or preventing heart damage with integrin-linked kinase (ilk) compositions |
| 05/19/2011 | US20110117184 Compositions for mucosal delivery of agents |